Display Settings:

Format

Send to:

Choose Destination

    Diabetes Care. 2008 Sep;31(9):1886-8. Epub 2008 Jun 5.

    Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects.

    Succurro E, Andreozzi F, Sciaqua A, Hribal ML, Perticone F, Sesti G.

    Department of Experimental and Clinical Medicine, University Magna-Graecia of Catanzaro, Catanzaro, Italy.

    OBJECTIVE: To examine the relationship between plasma IGF-1 and interleukin-6 (IL-6) levels in Caucasian nondiabetic subjects and evaluate the association of IGF-1 and IL-6 with the cardiometabolic risk factors characterizing metabolic syndrome (MetS). RESEARCH DESIGN AND METHODS: The study group consisted of 186 Caucasian nondiabetic subjects who underwent an oral glucose tolerance test and an euglycemic-hyperinsulinemic clamp. A logistic regression analysis, adjusted for age and sex, was used to determine the association between tertiles of IGF-1 and IL-6 and the MetS and its components. RESULTS: After adjusting for age and sex, both IGF-1 and IL-6 were correlated with insulin resistance and individual components of MetS, but in opposite directions. In the logistic regression model adjusted for age and sex, higher IL-6 and lower IGF-1 levels confer increased risk of having MetS and its two underlying pathophysiological abnormalities, i.e., visceral obesity and insulin resistance. CONCLUSIONS: The present results raise the possibility that lowered protection against inflammation, i.e., lower IGF-1 levels, may have a role in the development of MetS and its features, resulting in an imbalance between proinflammatory and anti-inflammatory proteins.

    PMID: 18535190 [PubMed - indexed for MEDLINE]

    PMCID: 2518365

    Supplemental Content

    Click here to read Click here to read